您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > AV-412
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
AV-412
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
AV-412图片
CAS NO:451493-31-5
包装与价格:
包装价格(元)
2 mg电议
5 mg电议
10 mg电议
25 mg电议
50 mg电议
100 mg电议
200 mg电议
1 mL*10 mM(in DMSO)电议

产品名称
MP412
产品介绍
AV-412 是一种EGFR抑制剂,抑制EGFR、EGFRL858R、EGFRT790M、EGFRL858R/T790M 和 ErbB2 的IC50值分别为0.75、0.5、0.79、2.3 和 19 nM。

产品描述

AV-412 is an EGFR inhibitor (EGFR, EGFR T790M, EGFR L858R, EGFR L858R/T790M and ErbB2 with IC50s of 0.75, 0.79, 0.5, 2.3, 19 nM).

体外活性

In cells, MP-412 inhibited autophosphorylation of EGFR and ErbB2 with IC(50) of 43 and 282 nM, respectively.?It also inhibited epidermal growth factor (EGF)-dependent cell proliferation with an IC(50) of 100 nM.?Moreover, MP-412 abrogated EGFR signaling in the gefitinib-resistant H1975 cell line, which harbors a double mutation of L858R and T790M in EGFR.

体内活性

In animal studies using cancer xenograft models, MP-412 (30 mg/kg) demonstrated complete inhibition of tumor growth of the A431 and BT-474 cell lines, which overexpress EGFR and ErbB2, respectively.?MP-412 suppressed autophosphorylation of EGFR and ErbB2 at the dose corresponding to its antitumor efficacy.?When various dosing schedules were applied, MP-412 showed significant effects with daily and every-other-day schedules, but not with a once-weekly schedule, suggesting that frequent dosing is preferable for this compound.?Furthermore, MP-412 showed a significant antitumor effect on the ErbB2-overexpressing breast cancer KPL-4 cell line, which is resistant to gefitinib.?These studies indicate that MP-412 has potential as a therapeutic agent for the treatment of cancers expressing EGFR and ErbB2, especially those resistant to the first generation of small-molecule inhibitors.

Cas No.

451493-31-5

分子式

C41H44ClFN6O7S2

分子量

851.41

别名

MP412

储存和溶解度

DMSO:25 mg/mL (29.36 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years